NCT04616742View on ClinicalTrials.gov

Study to Evaluate the Mass Babance and Biotransformation of [14C]SHR6390 in Healthy Adult Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

November 11, 2020

Primary Completion Date

January 8, 2021

Study Completion Date

May 1, 2021

Conditions
Healthy Adult Male Volunteers
Interventions
DRUG

[14C]SHR6390

Patients will receive single dose of orally \[14C\]SHR6390 on Day 1.

Trial Locations (1)

215006

First affiliated hospital,Soochow University, Suzhou

All Listed Sponsors
lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT04616742 - Study to Evaluate the Mass Babance and Biotransformation of [14C]SHR6390 in Healthy Adult Male Volunteers | Biotech Hunter | Biotech Hunter